Amarjit Atwal
Ophthalmology · Cheektowaga, NYNPI 1356346795
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Alcon at 49.1% of the total.
Across 134 payments — averaging $40.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- Johnson & Johnson Surgical Vision, Inc.$416
- Bausch & Lomb, A Division Of Bausch Health US, LLC$415
- Glaukos Corporation$357
- Rxsight Inc$324
- Aerie Pharmaceuticals, Inc.$210
- plus $1K from 16 others
Across 4 payments — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$20K
What the payments were for
- Food & beverage$5,435100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 58 | $2,671 |
| Johnson & Johnson Surgical Vision, Inc. | 10 | $416 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $415 |
| Glaukos Corporation | 3 | $357 |
| Rxsight Inc | 6 | $324 |
| Aerie Pharmaceuticals, Inc. | 11 | $210 |
| AbbVie(2 entities) | 8 | $135 |
| Abbott | 1 | $133 |
| Amgen | 1 | $125 |
| Ivantis, Inc | 2 | $121 |
| Sun Pharmaceutical Industries Inc. | 1 | $111 |
| Novartis | 6 | $107 |
| Tarsus Pharmaceuticals, Inc. | 4 | $83 |
| Dompe US, Inc. | 2 | $48 |
| Oyster Point Pharma, Inc. | 2 | $33 |
| Thea Pharma Inc. | 2 | $28 |
| Eyevance Pharmaceuticals LLC | 2 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Shire North American Group Inc | 1 | $19 |
| Ocular Therapeutix, Inc. | 1 | $18 |
| Sight Sciences, Inc. | 1 | $18 |
| Kala Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iDoseTR$345
- AcrySof IQ VIVITY$280
- Unity$263
- Centurion$263
- Hydrus Microstent$245
- AcrySof$220
- iStent$209
- iStent Infinite$137
- OCTRODE$133
- ENVISTA$133
- STELLARIS$133
- Wavelight Plus$131
- AcrySof IQ VIVITY IOL$130
- AcrySof IQ PanOptix$125
- TEPEZZA$125
- Clareon PanOptix Pro$125
- Whitestar Phacoemulsficiation System$121
- Luxor$116
- Constellation$116
- ORA$116
How this compares
$5,435 in reported general payments places this provider in the 80th percentile of 1,587 ophthalmology providers in New York.
Other ophthalmology in Cheektowaga
- David RubaltelliBrooklyn$8.9M
- Nathan RadcliffeNew York$2.1M
- Richard SpaideNew York$1.7M
- Eric DonnenfeldGarden City$1.4M
- Marguerite McDonaldOceanside$893K
- Joshua YoungNew York$814K
- David KleinmanRochester$730K
- Jonathan JonischGreat Neck$726K
- Joseph PanarelliNew York$541K
- Eric RosenbergNew York$434K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.